Renal hemodynamic changes induced by captopril and angiotensin-converting enzyme gene polymorphism

Nephron

Volumn 75, Issue 3, 1997, Pages 310-314

  Mizuiri, Sonoo ^a   Hemmi, Hiromichi ^a   Inoue, Akira ^a   Takano, Masaaki ^a   Kadomatsu, Satoshi ^a   Tanimoto, Hiroyuki ^a   Tanegashima, Masateru ^a   Hayashi, Ikuko ^a   Fushimi, Tatsuo ^a   Hasegawa, Akira ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; Captopril; Gene polymorphism; Renal hemodynamic changes

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; PRIORITY JOURNAL;

EID: 0031053270     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189554     Document Type: Article

References (20)

1. Tiret L, Rigal B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992:51:197-205.
2. Rigat B, Hubert C, Alhene-Gelas F, Cambien F. Crovcl P. Soubrier F: An inscrtion/deletion polymorphism in the angiotensin-1 converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990:86: 1343-1346.
3. Marre M. Bernadct P. Gallois Y. Savagner F. Guyene T. Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994:43:384-388.
4. Doria A. Warrant JH. Krolewsky AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin 1-converting enzyme gene. Diabetes 1994:43:690-695.
5. Mizuiri S. Hcmmi H, Inoue A. Yoshikawa H, Tanegashima M. Fushimi T. Ishigami M. Ama-gasaki Y. Ohara T. Shimatakc H. Hascgawa A: Angiotensin converting enzyme polymorphism and development of diabetic nephropathy in N1DDM. Nephron 1995;70:455-459.
6. Schlegel JU. Hamway SA: Individual renal plasma flow determination in 2 minutes. J Urol 1976;116:282-285.
7. Kasahara Y, Ashihara Y: Colorimetry of angiotensin-1 converting enzyme activity in serum. ClinChem 1981;27:1922-1925.
8. Rigat B. Hubert C, Corvol P. Soubrier F: PCR detection of the insertion/delction polymorphism of the human angiotensin gene converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase I). Nucleic Acids Res 1992:20:1443.
9. Soubrier F. Alhenc-Gelas F. Hubert C, Alle-grini J, John M, Tregear G, Corvol P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988:85:9386-9390.
10. Campbell DJ. Lawrence AC. Towrie A. Kladis A. Valentijin AJ: Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991:18:763-773.
11. Burns BK, Homma T, Harris RC: The intrare-nal renin angiotensin system. Semin Nephrol 1993;13:13-30.
12. Vos PF. Boer P, Bream B. Koomans HA: Efficacy of intrarenal ACE-inhibition estimated from the renal response to angiotensin I and II in humans. Kidney Int 1995;47:274-281.
13. Lawrence AC, Evin G, Kladis A. Campbell DJ: An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-termi-nal-dirccted antisera: Measurement of eight angiotensin peptides in human plasma. J Hyper-tens 1990;8:715-724.
14. Gavras I: Bradykinin-mediated effects of ACE inhibition. Kidney lnt 1992;42:1020-1029.
15. Fox J, Guan S, Hymel AA. Navar LG: Dietary Na and ACE inhibition effect on renal tissue angiotensin 1 and II and renal ACE activity in rats. Am J Physiol 1992:262:F902-F909.
16. Schmidt M, Giesen-Crouse E-M, Krieger J-P, Welsh C, Imbs J-L: Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin 1 on isolated rat kidney. J Cardiovasc Pharmacol 1986;8(suppl 10): 100-105.
17. Mitchell KD. Navar LG: Influence of intrare-nally generated angiotensin II on renal hemodynamics and tubular reabsorption. Renal Physiol Biochem 1991;14:155-163.
18. Harden PN, Geddes C. Rowe PA. Mcllroy JH, Boulton-Jones M. Rodger RSC. Junor BJR. Briggs JD, Connell JM. Jardine AG: Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995;345:1540-1542.
19. Ueda S, Elliot HE, Morton JJ. Connel JMC: Enhanced pressor response to angiotensin II in normotensive males with deletion genotype (DD) for angiotensin converting enzyme. Hypertension, in press.
20. Sibony M, Gasc JM. Soubrier F, Alhenc-Gelas F. Corvol P: Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 1993;21: 827-835.